LFSC

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change +1.50
Percentage change 7.16	%

Category	US Equities - Factor & Thematic	Asset Type	Equities (Stocks)	Tags	Developed	Return% 1Y	-	Shs Outstand		Perf Week	8.63%
Sponsor	F/m Investments	ETF Type		Tags	equity	Return% 3Y	-	Total Holdings	32	Perf Month	-2.13%
Fund Family		Bond Type		Tags	innovation	Return% 5Y	-	AUM	50.21M	Perf Quarter	-8.08%
Index	-	Average Maturity		Tags	healthcare	Return% 10Y		NAV%		Perf Half Y	-
Index Weighting		Commodity Type		Tags	biotechnology	Return% SI		NAV/sh		Perf Year	-
Active/Passive		Quant Type		Tags	medical	Flows% 1M	-3.29%	52W Range	18.78 - 27.76	Perf YTD	-4.06%
Dividend TTM	-	ESG Type		Tags	pharmaceutical	Flows% 3M	7.45%	52W High	-19.16%	Beta	-
Dividend Ex-Date	-	Dividend Type		Sector/Theme		Flows% YTD	8.08%	52W Low	19.50%	ATR (14)	0.74
Expense	0.54%	Structure Type		Region		Flows% 1Y		RSI (14)	53.64	Volatility	0.56% 1.99%
Option/Short	No / Yes	Growth/Value		Dev/Emerg		Flows% 3Y		Rel Volume	0.06	Prev Close	20.94
Inverse/Leveraged		Market Cap		Currency		Flows% 5Y		Avg Volume	4.29K	Price	22.44
SMA20	4.70%	SMA50	-1.85%	SMA200	-7.48%	Trades		Volume	255	Change	7.16%

Feb-04-25 10:15AM	Shining a Light on New Investment Opportunities: Small Caps Emerge from the Shadows at the Groundhog Investment Conference (Business Wire)
Oct-31-24 07:30AM	Emerald Advisers and F/m Investments Announce the Launch of the F/m Emerald Life Sciences Innovation ETF (LFSC) (Business Wire)

F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

open in yahoo | open in marketwatch | open in google

F/m Emerald Life Sciences Innovation ETF

Upgrade your FINVIZ experience